Capricor Therapeutics Inc
NASDAQ:CAPR

Watchlist Manager
Capricor Therapeutics Inc Logo
Capricor Therapeutics Inc
NASDAQ:CAPR
Watchlist
Price: 19.18 USD 1.91% Market Closed
Market Cap: 858.1m USD
Have any thoughts about
Capricor Therapeutics Inc?
Write Note

Cash Flow Statement

Cash Flow Statement
Capricor Therapeutics Inc

Rotate your device to view
Cash Flow Statement
Currency: USD
Sep-2014 Dec-2014 Mar-2015 Jun-2015 Sep-2015 Dec-2015 Mar-2016 Jun-2016 Sep-2016 Dec-2016 Mar-2017 Jun-2017 Sep-2017 Dec-2017 Mar-2018 Jun-2018 Sep-2018 Dec-2018 Mar-2019 Jun-2019 Sep-2019 Dec-2019 Mar-2020 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024 Jun-2024 Sep-2024
Operating Cash Flow
Net Income
(12)
(6)
(8)
(10)
(11)
(13)
(14)
(15)
(18)
(19)
(18)
(17)
(14)
2
2
2
0
(15)
(14)
(12)
(9)
(8)
(7)
(9)
(11)
(14)
(17)
(18)
(18)
(20)
(23)
(25)
(27)
(29)
(29)
(29)
(29)
(22)
(24)
(28)
(34)
Depreciation & Amortization
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
1
1
1
1
1
1
Stock-Based Compensation
0
1
1
1
1
2
1
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
2
2
2
2
3
3
3
4
4
4
6
6
7
7
8
9
0
Other Non-Cash Items
2
1
1
1
1
2
1
2
2
3
4
3
3
(14)
(14)
(14)
(14)
2
1
1
1
1
1
1
2
2
2
2
2
3
3
4
4
5
6
6
7
7
8
9
9
Cash Taxes Paid
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Cash Interest Paid
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Change in Working Capital
7
7
(5)
0
1
0
(1)
(2)
1
1
(1)
(0)
(4)
(3)
(2)
(1)
1
(1)
0
0
(1)
(0)
(0)
0
1
2
2
1
0
0
30
29
29
29
8
5
1
(12)
(16)
(16)
(13)
Cash from Operating Activities
(3)
N/A
1
N/A
(12)
N/A
(8)
+33%
(9)
-12%
(11)
-16%
(13)
-20%
(16)
-23%
(15)
+8%
(14)
+1%
(15)
-3%
(14)
+8%
(15)
-9%
(14)
+5%
(13)
+9%
(13)
N/A
(13)
+2%
(14)
-9%
(12)
+13%
(10)
+16%
(9)
+13%
(7)
+23%
(6)
+6%
(7)
-4%
(8)
-20%
(10)
-26%
(12)
-21%
(15)
-21%
(15)
-2%
(17)
-12%
11
N/A
9
-19%
6
-27%
5
-21%
(15)
N/A
(18)
-19%
(21)
-17%
(26)
-22%
(31)
-21%
(34)
-9%
(37)
-8%
Investing Cash Flow
Capital Expenditures
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
0
0
0
(0)
(0)
(1)
(1)
(1)
(1)
(1)
(2)
(2)
(3)
(3)
(3)
(3)
(3)
(2)
(2)
(2)
(2)
Other Items
4
0
(15)
(15)
(13)
(8)
13
13
10
(5)
(6)
(1)
(2)
5
3
(2)
(1)
5
6
6
6
(3)
0
0
0
6
0
0
0
0
0
(35)
(38)
(32)
(34)
7
19
7
1
9
3
Cash from Investing Activities
4
N/A
0
-96%
(15)
N/A
(15)
+0%
(13)
+16%
(8)
+36%
13
N/A
13
N/A
10
-19%
(5)
N/A
(7)
-28%
(2)
+75%
(3)
-61%
5
N/A
3
-44%
(2)
N/A
(1)
+40%
5
N/A
6
+25%
6
N/A
6
+2%
(3)
N/A
0
N/A
(0)
N/A
(0)
-150%
5
N/A
(1)
N/A
(1)
-36%
(1)
-40%
(1)
-7%
(2)
-49%
(37)
-1 960%
(41)
-10%
(35)
+14%
(38)
-7%
4
N/A
16
+282%
5
-68%
(1)
N/A
7
N/A
1
-81%
Financing Cash Flow
Net Issuance of Common Stock
0
0
16
16
16
16
4
4
14
14
10
14
8
11
14
13
9
7
6
4
5
9
12
37
36
33
41
17
22
20
8
7
2
5
5
7
5
26
28
28
95
Net Issuance of Debt
9
5
0
1
0
0
1
3
5
5
4
2
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Cash from Financing Activities
9
N/A
5
-41%
22
+316%
17
-22%
16
-3%
16
N/A
5
-70%
7
+40%
19
+168%
19
N/A
14
-26%
16
+14%
9
-45%
12
+35%
14
+22%
13
-8%
9
-28%
7
-27%
6
-16%
4
-39%
5
+44%
9
+81%
12
+34%
37
+200%
37
-1%
33
-9%
41
+24%
17
-58%
22
+25%
20
-7%
8
-62%
7
-13%
2
-70%
5
+147%
5
-1%
7
+45%
5
-24%
26
+377%
28
+9%
28
0%
95
+242%
Change in Cash
Net Change in Cash
10
N/A
6
-34%
(6)
N/A
(7)
-9%
(6)
+15%
(2)
+56%
5
N/A
4
-21%
14
+277%
(1)
N/A
(8)
-681%
0
N/A
(9)
N/A
2
N/A
4
+68%
(2)
N/A
(5)
-112%
(2)
+50%
(0)
+81%
(1)
-73%
2
N/A
(1)
N/A
6
N/A
30
+413%
28
-6%
29
+2%
29
0%
2
-94%
6
+202%
2
-60%
16
+641%
(22)
N/A
(32)
-49%
(25)
+22%
(48)
-89%
(7)
+86%
1
N/A
5
+793%
(4)
N/A
1
N/A
59
+6 846%
Free Cash Flow
Free Cash Flow
(3)
N/A
1
N/A
(13)
N/A
(8)
+33%
(9)
-12%
(11)
-16%
(13)
-20%
(16)
-23%
(15)
+9%
(15)
+1%
(15)
-3%
(14)
+8%
(15)
-9%
(14)
+6%
(13)
+8%
(13)
+0%
(13)
+1%
(14)
-8%
(12)
+14%
(10)
+16%
(9)
+14%
(7)
+23%
(6)
+6%
(7)
-5%
(8)
-22%
(11)
-28%
(13)
-20%
(15)
-21%
(16)
-4%
(18)
-12%
9
N/A
7
-24%
4
-45%
2
-58%
(18)
N/A
(21)
-15%
(23)
-13%
(28)
-18%
(33)
-21%
(36)
-8%
(38)
-6%

See Also

Discover More